Taping and PMR Effects in Primary Dysmenorrhea

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-25
SponsorRiphah International University

About this trial

The study is randomized controlled trial,The study conducted in two groups. Group A has given the kinesiology taping on the lower abdomen and back for 1-3 days with progressive muscle relaxation technique for 10-20 minutes and a baseline treatment hot pack at a time twice a day from the start of menstruation and Group B has receive the kinesiology taping on the lower abdomen and baseline treatment hot pack without progressive muscle relaxation technique for 1-3 days. The total treatment duration will be 6 weeks. The rationale of this study is to provide empirical evidence regarding the efficacy and safety of kinesiology taping and progressive muscle relaxation. By investigating the potential benefits of this intervention, healthcare professionals can make informed decisions about incorporating K-taping and PMR in primary dysmenorhea. Focusing on the impact of kinesiology taping and progressive muscle relaxation on pain,anxiety, and body awareness aligns with a patient-centered approach to care. The goal is not only to reduce symptoms but also to enhance overall well-being and functional capacity

Eligibility criteria

Qualifiers

• Aged between 18-25 years

Unmarried female

Taking ≥4 points from Visual Analog Scale during menstrual cycle

Had moderate menstrual pain as measured by WaLLID score

Disqualifiers

• Complaints of low back pain due to any other pathology, any skin infection, sensitive skin or allergic to Kinesio Tape.

PCOD, Uterine/ ovarian tumor, Acute/ chronic pelvic pathology like PID, endometriosis, spinal pathology and deformity

Endometrial polyp, having a pelvic infection, using an intrauterine device, having venous congestion in the internal genital organs.

Who take analgesic

Trial design

Treatments tested in this trial

  • hot pack , K taping , Progressive muscle relaxation

Treatment groups

30 Participants
are divided into 2 treatment groups